Studies genetic architecture, pharmacogenetic signals and brain pathology underlying neurodegeneration. Integrates genome-wide studies, sequencing, single‑cell profiling and neuropathology to map mechanisms across Parkinson’s, Lewy body dementia, Alzheimer’s and tauopathies—informing biomarkers, stratification and targets.